S. Howell

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

U. Wieshmann, A. Chaudhuri, J. Gibb, 2021, The Lancet.

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial

Mark Johnson, J. Read, J. Mellers, 2020, The lancet. Psychiatry.